Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Torpedo Pharmaceuticals AG

History from 15 Nov 2021

UID
CHE-233.665.087
Legal form
AG
Canton
BS
Founded
15 Nov 2021
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 105k
26k53k79k105k28 Apr 2025 · CHF 101k26 May 2025 · CHF 103k26 Aug 2025 · CHF 105k
  • shares

Record

  1. Company formed

    Founded 15 Nov 2021

    SHAB HR01-1005336920 ↗
  2. Name changed

    Swiss Rockets Pharma AG → Torpedo Pharmaceuticals AG

    SHAB HR02-1005796912 ↗
  3. Capital increase

    Not assessed

    Paid by converting claims

    Nominal capital
    100’000 → 101’473.34
    Shares
    10’000’000 → 10’147’334
    New shares, % of post-step shares
    1.5% (147’334 new)

    Aktienkapital neu: CHF 101'473.34 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 101'473.34 [bisher: CHF 100'000.00]. Aktien neu: 10'147'334 Namenaktien zu CHF 0.01 [bisher: 10'000'000 Namenaktien zu CHF 0.01]. Partizipationskapital neu: CHF 536.41. Liberierung Partizipationskapital neu: CHF 536.41. Partizipationsscheine neu: 53'641 Namen-Partizipationsscheine zu CHF 0.01. Kapitalband gemäss näherer Umschreibung in den Statuten.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006318351 ↗
  4. Capital band adopted

    SHAB HR02-1006318351 ↗
  5. Capital increase

    Not assessed

    Paid by converting claims

    Nominal capital
    101’473.34 → 102’575.54
    Shares
    10’147’334 → 10’257’554
    New shares, % of post-step shares
    1.1% (110’220 new)

    Aktienkapital neu: CHF 102'575.54 [bisher: CHF 101'473.34]. Liberierung Aktienkapital neu: CHF 102'575.54 [bisher: CHF 101'473.34]. Aktien neu: 10'257'554 Namenaktien zu CHF 0.01 [bisher: 10'147'334 Namenaktien zu CHF 0.01]. Partizipationskapital neu: CHF 576.83 [bisher: CHF 536.41]. Liberierung Partizipationskapital neu: CHF 576.83 [bisher: CHF 536.41]. Partizipationsscheine neu: 57'683 Namen-Partizipationsscheine zu CHF 0.01 [bisher: 53'641 Namen-Partizipationsscheine zu CHF 0.01]. Ordentliche Kapitalerhöhung innerhalb Kapitalband. Ordentliche Kapitalerhöhung innerhalb Kapitalband, wobei 50'220 Namenaktien zu CHF 0.01 durch Verrechnung einer Forderung von CHF 502'200.00 liberiert werden.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006340943 ↗
  6. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    102’575.54 → 105’278.25
    Shares
    10’257’554 → 10’527’825
    New shares, % of post-step shares
    2.6% (270’271 new)

    Aktienkapital neu: CHF 105'278.25 [bisher: CHF 102'575.54]. Liberierung Aktienkapital neu: CHF 105'278.25 [bisher: CHF 102'575.54]. Aktien neu: 10'527'825 Namenaktien zu CHF 0.01 [bisher: 10'257'554 Namenaktien zu CHF 0.01]. Ordentliche Kapitalerhöhung innerhalb Kapitalband.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.65 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006416952 ↗

Published by 31 Aug 2025

Latest available record · 8 Oct 2026